Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07043608
What this trial is testing

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Clear Cell Renal CarcinomaClear Cell Renal Cell Carcinoma Metastatic+7 more
Kelly Fitzgerald, MD 20
Large-scale testing (Phase 3)Study completedNCT00053820
What this trial is testing

Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Medical Research Council 670
Testing effectiveness (Phase 2)Study completedNCT00467025
What this trial is testing

AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib

Who this might be right for
Advanced Renal Cell Carcinoma
Amgen 152
Early research (Phase 1)Study completedNCT04440943
What this trial is testing

The PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerBreast CancerGastric Cancer+11 more
Celldex Therapeutics 27
Not applicableLooking for participantsNCT07321197
What this trial is testing

Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carcinoma (T-LND RCC)

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)
Tianjin Medical University Second Hospital 220
Testing effectiveness (Phase 2)Study completedNCT00480389
What this trial is testing

Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal

Who this might be right for
Renal Cell CarcinomaMetastatic Disease
University Health Network, Toronto 19
Not applicableUnknownNCT04245410
What this trial is testing

Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma

Who this might be right for
Surgical ProcedureDisease Free SurvivalOverall Survival
Universidad de Extremadura 100
Testing effectiveness (Phase 2)Looking for participantsNCT05663710
What this trial is testing

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

Who this might be right for
Advanced CancerClear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 100
Early research (Phase 1)Study completedNCT06894771
What this trial is testing

MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 5
Testing effectiveness (Phase 2)Study completedNCT00044564
What this trial is testing

Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 54
Not applicableStudy completedNCT02184416
What this trial is testing

Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting

Who this might be right for
Metastatic Renal Cell Carcinoma (mRCC)
Pfizer 554
Testing effectiveness (Phase 2)Study completedNCT01136733
What this trial is testing

E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment

Who this might be right for
Metastatic Renal Cell Carcinoma
Eisai Inc. 173
Testing effectiveness (Phase 2)Study completedNCT06059014
What this trial is testing

Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Centre Leon Berard 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04322955
What this trial is testing

CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition

Who this might be right for
Kidney CancerRenal Cell Carcinoma
Mark Stein 38
Not applicableUnknownNCT04891055
What this trial is testing

Prospective Translational Study Investigating Predictors of Outcome in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab (I-Rene Trial)

Who this might be right for
Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 90
Early research (Phase 1)Study completedNCT04834778
What this trial is testing

HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)

Who this might be right for
Renal Cell CarcinomaGastric CancerMetastatic Breast Cancer+2 more
HiberCell, Inc. 23
Large-scale testing (Phase 3)Study completedNCT01668784
What this trial is testing

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

Who this might be right for
Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
Bristol-Myers Squibb 821
Not applicableStudy completedNCT05432947
What this trial is testing

68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 42
Testing effectiveness (Phase 2)Study completedNCT00486538
What this trial is testing

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

Who this might be right for
Advanced Renal Cell Carcinoma
AbbVie (prior sponsor, Abbott) 53
Testing effectiveness (Phase 2)Study completedNCT02996110
What this trial is testing

Test Combination Treatments in People With Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 182
Next Page